Amidst a significant net loss increase, Omeros Corp navigates through promising drug trials and strategic royalty milestones.
Amidst robust revenue growth and operational optimizations, Bakkt Holdings Inc reports significant strides in financial health and strategic positioning.
Despite a tough quarter, Velo3D Inc (VLD) outlines strategic adjustments and optimistic revenue forecasts for 2024.